Cho M, Webster S G, Blau H M
Department of Pharmacology, Stanford University School of Medicine, California 94305-5332.
J Cell Biol. 1993 May;121(4):795-810. doi: 10.1083/jcb.121.4.795.
Vertebrate muscles are composed of an array of diverse fast and slow fiber types with different contractile properties. Differences among fibers in fast and slow MyHC expression could be due to extrinsic factors that act on the differentiated myofibers. Alternatively, the mononucleate myoblasts that fuse to form multinucleated muscle fibers could differ intrinsically due to lineage. To distinguish between these possibilities, we determined whether the changes in proportion of slow fibers were attributable to inherent differences in myoblasts. The proportion of fibers expressing slow myosin heavy chain (MyHC) was found to change markedly with time during embryonic and fetal human limb development. During the first trimester, a maximum of 75% of fibers expressed slow MyHC. Thereafter, new fibers formed which did not express this MyHC, so that the proportion of fibers expressing slow MyHC dropped to approximately 3% of the total by midgestation. Several weeks later, a subset of the new fibers began to express slow MyHC and from week 30 of gestation through adulthood, approximately 50% of fibers were slow. However, each myoblast clone (n = 2,119) derived from muscle tissues at six stages of human development (weeks 7, 9, 16, and 22 of gestation, 2 mo after birth and adult) expressed slow MyHC upon differentiation. We conclude from these results that the control of slow MyHC expression in vivo during muscle fiber formation in embryonic development is largely extrinsic to the myoblast. By contrast, human myoblast clones from the same samples differed in their expression of embryonic and neonatal MyHCs, in agreement with studies in other species, and this difference was shown to be stably heritable. Even after 25 population doublings in tissue culture, embryonic stage myoblasts did not give rise to myoblasts capable of expressing MyHCs typical of neonatal stages, indicating that stage-specific differences are not under the control of a division dependent mechanism, or intrinsic "clock." Taken together, these results suggest that, unlike embryonic and neonatal MyHCs, the expression of slow MyHC in vivo at different developmental stages during gestation is not the result of commitment to a distinct myoblast lineage, but is largely determined by the environment.
脊椎动物的肌肉由一系列具有不同收缩特性的快肌纤维和慢肌纤维组成。快肌和慢肌肌球蛋白重链(MyHC)表达的差异可能是由于作用于分化肌纤维的外在因素。或者,融合形成多核肌纤维的单核成肌细胞可能由于谱系而存在内在差异。为了区分这些可能性,我们确定了慢肌纤维比例的变化是否归因于成肌细胞的固有差异。发现在胚胎期和胎儿期人类肢体发育过程中,表达慢肌球蛋白重链(MyHC)的纤维比例随时间显著变化。在妊娠早期,最多75%的纤维表达慢MyHC。此后,形成了不表达这种MyHC的新纤维,因此到妊娠中期,表达慢MyHC的纤维比例降至约占总数的3%。几周后,一部分新纤维开始表达慢MyHC,从妊娠30周直至成年,约50%的纤维为慢肌纤维。然而,从人类发育六个阶段(妊娠第7、9、16和22周、出生后2个月和成年)的肌肉组织中获得的每个成肌细胞克隆(n = 2119)在分化时都表达慢MyHC。从这些结果我们得出结论,在胚胎发育过程中肌肉纤维形成期间,体内慢MyHC表达的控制在很大程度上是成肌细胞外在的因素。相比之下,来自相同样本的人类成肌细胞克隆在胚胎和新生儿MyHC的表达上存在差异,这与其他物种的研究结果一致,并且这种差异被证明是稳定可遗传的。即使在组织培养中经过25次群体倍增后,胚胎期的成肌细胞也不会产生能够表达新生儿期典型MyHC的成肌细胞,这表明阶段特异性差异不受分裂依赖机制或内在“时钟”的控制。综上所述,这些结果表明,与胚胎和新生儿MyHC不同,妊娠期间不同发育阶段体内慢MyHC的表达不是由于特定成肌细胞谱系的定向分化,而是在很大程度上由环境决定。